Skip to content
Z Zendikt
N
Healthcare EHR Software · Rank #4 of 10

NextGen Healthcare review and pricing

Thoma Bravo Nov 2024 take-private at $1.8B; strong ambulatory fit, flag PE pressure.

By NextGen Healthcare (Thoma Bravo) · Founded 1998 · Atlanta, GA · pe backed

NextGen Healthcare is the long-running ambulatory EHR platform, founded 1998. Public NASDAQ:NXGN 2008-2024. Thoma Bravo announced take-private acquisition August 2024, completed November 2024 at $1.8B ($23.95/share). The platform centers on ambulatory EHR + practice management + revenue cycle for mid-market physician groups. Strengths: mid-market ambulatory sweet spot, mature 25-year track record, broad specialty support (cardiology, orthopedics, primary care), strong revenue cycle integration, and Thoma Bravo capital for AI investment. Best fit for mid-market physician groups (25-500 physicians) wanting NextGen-anchored ambulatory workflow. Trade-offs: Thoma Bravo PE pressure pattern (pricing escalations typical 6-18 months post-take-private), implementation 4-12 months, customer support quality variable, AI features below Epic/athenahealth on velocity, and recently-private creates roadmap uncertainty.

Visit NextGen Healthcare Vendor pricing Compare to athenahealth
Best for

Mid-market physician groups (25-500 physicians) wanting NextGen-anchored ambulatory workflow with broad specialty support.

Worst for

Hospital scope (Epic/Cerner better), enterprise practices ($50M+ revenue) wanting more modern alternatives (athenahealth/Epic), or buyers concerned about Thoma Bravo PE pattern.

Vendor Trust Score

Is NextGen Healthcare a trustworthy vendor?

6.2/10
Mixed
Pricing transparency
Published rates; no hidden fees
4.5
Contract fairness
Reasonable terms; no auto-renew traps
6.5
Incident response
How they handle outages and breaches
7.0
Post-acquisition behavior
Customer treatment after M&A or PE
5.5
Executive stability
Leadership churn over 24 months
7.0
Roadmap honesty
Public commitments held
6.5
Trust signal log
  • 2008-04-22
    IPO on NASDAQ:NXGN
  • 2024-08-22
    Thoma Bravo take-private agreement announced at $1.8B
  • 2024-11-22
    Thoma Bravo take-private closed; NextGen delisted from NASDAQ
Vendor Trust is scored independently of product quality. A great product from an unfair vendor still earns a low trust score.
Review Intelligence

What 480 reviews actually say

Synthesized from G2, Capterra, Reddit, Trustpilot. Patterns >15% prevalence shown.

Last synthesized
2026-04-29

Praise patterns

  • Mid-market ambulatory sweet spot
    78% →
  • Mature 25-year track record
    64% →
  • Broad specialty support
    51% →
  • Revenue cycle integration
    41% →

Complaint patterns

  • Thoma Bravo PE pressure expected
    64% ↑
  • Implementation 4-12 months
    47% →
  • AI features below leaders
    41% ↑
  • Customer support variable
    38% →
Sentiment trend (6 months)
66/100 0 pts
12
01
02
03
04
05
Patterns are extracted from review corpus and human-verified. We surface trends, not anecdotes.
Verified Pricing

What buyers actually pay

92 anonymized deal disclosures · last updated 2026-05-01

Contribute your deal price
Company size Median annual
25-100 physicians $240,000
100-500 physicians $920,000
500+ physicians $3,200,000
Verified pricing is crowdsourced from buyers under anonymity guarantees. Vendor-listed prices are validated against actual deals quarterly.
Compliance & Security

Auto-verified certifications

Verified 2026-05-01
SOC 2 Type II
ISO 27001
HIPAA
GDPR
CCPA
PCI DSS
◐ FedRAMP In-Process

Editorial: Strengths

  • Mid-market ambulatory sweet spot
  • Mature 25-year track record
  • Broad specialty support
  • Strong revenue cycle integration
  • Thoma Bravo capital for AI investment
  • Atlanta engineering culture

Editorial: Weaknesses

  • Thoma Bravo PE pressure pattern (pricing escalations expected)
  • Implementation 4-12 months
  • Customer support variable
  • AI features below Epic/athenahealth
  • Recently-private roadmap uncertain
  • Per-physician + module pricing complex

Key features & integrations

  • +Ambulatory clinical EHR
  • +Practice management
  • +Revenue cycle
  • +Patient portal
  • +Specialty-specific templates
  • +Telehealth
  • +Carequality
  • +60+ integrations
60+ integrations
SurescriptsCarequalityCommonWellAWSMicrosoft DAX Copilot
Geography supported
Primary US
Best fit
25–5,000 employees · Mid-market physician groups
Editorial deep-dive

Read our full ranking of Healthcare EHR Software

NextGen Healthcare ranks #4 in our editorial review of 10 healthcare ehr software platforms. The deep-dive covers methodology, comparison tables, decision matrix, migration scoring, and FAQs.

Read the full ranking

Closest alternatives in Healthcare EHR Software

#3
athenahealth
Ambulatory practice + physician group leader; flag Bain plus Hellman and Friedman 2022 take-private at $17B.
★ 3.9 opaque
#5
Veradigm (formerly Allscripts)
Allscripts rebranded to Veradigm 2022; delisted from NASDAQ 2024; major vendor stability concerns.
★ 3.4 opaque
#2
Cerner (Oracle Health)
Oracle-acquired 2022 for $28.3B; flag Oracle integration struggles plus customer migrations to Epic.
★ 3.5 opaque
Help the next buyer

Contribute your verified deal price

Pricing in B2B software is opaque because vendors want it that way. Verified buyer prices fix that, anonymously. Share what you actually paid for NextGen Healthcare; we’ll add it to the verified pricing dataset on this page (with company size band only, no identifying details).

Submit anonymously